AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO saysAI is used by Sanofi to make unbiased decisions on drug development, as it lacks personal attachments.
CEO of pharma giant Sanofi says businesses should stop 'AI washing'AI in healthcare has enormous potential, yet there is a trend of exaggeration by executives about its current capabilities.
Hands off our DolipraneThe planned sale of Doliprane has sparked a significant political backlash in France, reflecting deep concerns over national sovereignty and health security.
Sanofi profit lifted by early vaccine sales, dupixent growthStrong profit growth due to seasonal vaccines and Dupixent sales.Sanofi increases annual profit forecast amid exclusive negotiations for consumer health unit.
France to take stake in Sanofi unit to quell backlash over sale to US firmThe French government will stake in Sanofi's consumer healthcare to prevent job losses amid the sale discussions with a private equity firm.
Hands off our DolipraneThe planned sale of Doliprane has sparked a significant political backlash in France, reflecting deep concerns over national sovereignty and health security.
Sanofi profit lifted by early vaccine sales, dupixent growthStrong profit growth due to seasonal vaccines and Dupixent sales.Sanofi increases annual profit forecast amid exclusive negotiations for consumer health unit.
France to take stake in Sanofi unit to quell backlash over sale to US firmThe French government will stake in Sanofi's consumer healthcare to prevent job losses amid the sale discussions with a private equity firm.